Fungal Pathogenesis at the Host–Pathogen Interface: Immune Recognition, Evasion, Antifungal Resistance, and…

Real‐World Survival Outcomes of Venetoclax Combination Therapies in Acute Myeloid Leukemia: Impact of Minimal Residual Disease Status and Antifungal Prophylaxis
Mariarita Sciumè, Alessandro Bosi, Alfredo Marchetti +7
Hematological oncology13 Oct 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
The BAFF/APRIL system in autoimmune nephropathy: from pathogenesis to targeted biologic therapies.
Yingjie Jia, Zhenping Yu, Yamin Xue +3
Frontiers in medicine8 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Genome architecture drives antifungal resistance in Candida auris
Anuradha Chowdhary, Nityendra Shukla, Neeraj Chauhan
Nature Communications9 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseCrossref
MARDy 2.0: a platform for exploring and analysing antifungal resistance mutations
Joe Webber, Hugh Gifford, Johanna Rhodes +1
Bioinformatics19 Oct 2026Peer-reviewedCC BY 4.0Full textInfectious diseaseCrossrefPMC
Fosmanogepix: A comprehensive review of its origin, mechanism, antifungal efficacy, and resistance (Review).
Guoxing Zhu, Nanyi Zheng, Pengfei Zhai +1
Biomedical reports23 Sep 2026Peer-reviewedCC BY-NC-NDFull textInfectious diseaseEurope PMC

Cite

BibTeX

@article{anon2026fungal,
  title = {{Fungal Pathogenesis at the Host–Pathogen Interface: Immune Recognition, Evasion, Antifungal Resistance, and Emerging Therapies}},
  journal = {Tropical medicine and infectious disease},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13709810},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - Fungal Pathogenesis at the Host–Pathogen Interface: Immune Recognition, Evasion, Antifungal Resistance, and Emerging Therapies
PY  - 2026
DA  - 2026/09/30
JO  - Tropical medicine and infectious disease
UR  - https://europepmc.org/article/PMC/PMC13709810
SN  - 2414-6366
ER  -

Related

Cite